Stability and robustness of blood variables in an antidoping context

International Journal of Laboratory Hematology

Volumn 33, Issue 2, 2011, Pages 146-153

  Robinson, N ^a   Sottas, P E ^a   Pottgiesser, T ^b   Schumacher, Y O ^b   Saugy, M ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Blood; Doping; Guidelines; Passport; Stability

Indexed keywords

HEMOGLOBIN;

ANALYZER; ARTICLE; BLOOD SAMPLING; CYCLING; DOPING; HEMOGLOBIN ANALYSIS; HUMAN; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RETICULOCYTE;

ATHLETES; DOPING IN SPORTS; HEMATOLOGIC TESTS; HUMANS; MALE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 79952476472     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2010.01256.x     Document Type: Article

References (36)

1. Ahlgrim C., Pottgiesser T., Robinson N., Sottas P.E., Ruecker G. & Schumacher Y.O. (2010) Are 10min of seating enough to guarantee stable haemoglobin and haematocrit readings for the athlete's biological passport? International Journal of Laboratory Hematology in press.
2. Ashenden M.J., Sharpe K., Damsgaard R. & Jarvis L. (2004) Standardization of reticulocyte values in an antidoping context. American Journal of Clinical Pathology 121, 816-825.
3. Banfi G. (2008) Reticulocytes in sports medicine. Sports medicine 38, 187-211.
4. Bellamy G.J. & Hinchliffe R.F. (1990) Effect of storage on blood count variables in small samples. Medical Laboratory Sciences 47, 230-233.
5. Berg B., Estborn B. & Tryding N. (1981) Stability of serum and blood constituents during mail transport. Scandinavian Journal of Clinical Laboratory Investigation 41, 425-430.
6. Bland J. & Altman D. (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307-310.
7. Buttarello M., Bulian P., Farina G., Temporin V., Toffolo L., Trabuio E. & Rizzotti P. (2001) Flow cytometric reticulocyte counting. Parallel evaluation of five fully automated analyzers: an NCCLS-ICSH approach. American Journal of Clinical Pathology 115, 100-111.
8. Cavill I., Kraaijenhagen R., Pradella R., D'Onofrios G., Herkner K., Rowan R.M., Theodorsen L. & Tichelli T. (1996) In vitro stability of the reticulocyte count. Clinical and Laboratory Haematology 18, 9-1.
9. Cohle S.D., Saleem A. & Makkaoui D.E. (1981) Effects of storage of blood on stability of hematologic parameters. American Journal of Clinical Pathology 76, 67-69.
10. Dimopoulou H.A., Theodoridis T., Galea V., Christopoulou-Cokkinou V., Spyridaki M.H. & Georgakopoulos C.G. (2007) ISO/IEC 17025 Sysmex R-500 hematology reticulocyte analyzer validation. Laboratory Hematology 13, 43-48.
11. Felding P., Hyltoft Petersen P. & Horder M. (1981) The stability of blood, plasma and serum constituents during simulated transport. Scandinavian Journal of Clinical Laboratory Investigation 41, 35-40.
12. Giraud S., Sottas P.E., Robinson N. & Saugy M. (2010) Blood transfusion in sports. Handbook of Experimental Pharmacology 195, 295-304.
13. Gronowicz G., Swift H. & Steck T.L. (1984) Maturation of the reticulocyte in vitro. Journal of Cell Science 71, 177-197.
14. Guder W.G. (1999) Preanalytical factors and their influence on analytical quality specifications. Scandinavian Journal of Clinical Laboratory Investigation 59, 545-550.
15. Guder W.G., Narayanan S., Wisser H. & Zawta B. (1996) Samples: From the Patient to the Laboratory: the Impact of Preanalytical Variables on the Quality of Laboratory Results. GIT Verlag, Darmstadt.
16. Imeri F., Herklotz R., Risch L., Arbetsleitner C., Zerlauth M., Risch G.M. & Huber A.R. (2008) Stability of hematological analytes depends on the hematology analyser used: a stability study with Bayer Advia 120, Beckman Coulter LH 750 and Sysmex XE 2100. Clinica Chimica Acta 397, 68-71.
17. International Cycling Union (2009) Anti-Doping Procedural Guideline, Conducting a blood sample collection session V6.0, UCI
18. ISO/IEC 17025 (2005) General Requirements for the Competence of Calibration and Testing Laboratories
19. Lippi G., Salvagno G.L., Solero G.P., Franchini M. & Guidi G.C. (2005) Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer. Journal of Laboratory and Clinical Medicine 146, 333-340.
20. Malcovati L., Pascutto C. & Cazzola M. (2003) Hematologic passport for athletes competing in endurance sports: a feasibility study. Haematologica 88, 570-581.
21. Morihara H., Shirakami A., Wada K. & Fujimoto K. (2000) Introduction of the XE-2100 online QC System. Sysmex Journal International 10, 13-17.
22. Narayanan S. (2000) The preanalytic phase: an important component of laboratory medicine. American Journal of Clinical Pathology 113, 429-452.
23. Robinson N., Mangin P. & Saugy M. (2004) Time and temperature dependant changes in red blood cell analytes used for testing recombinant erythropoietin abuse in sports. Clinical Laboratory 50, 317-323.
24. Robinson N., Sottas P.E., Mangin P. & Saugy M. (2007) Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes. Haematologica 92, 1143-1144.
25. Schumacher Y.O., Wenning M., Robinson N., Sottas P.E., Ruecker G. & Pottgiesser T. (2010) Diurnal and exercise-related variability of haemoglobin and reticulocytes in athletes. International Journal of Sports Medicine 31, 225-230.
26. Sharpe K., Ashenden M.J. & Schumacher Y.O. (2006) A third generation approach to detect erythropoietin abuse in athletes. Haematologica 91, 356-363.
27. Sharpe K., Hopkins W., Emslie K.R., Howe C., Trout G.J., Kazlauskas R., Ashenden M.J., Gore C.J., Parisotto R. & Hahn A.G. (2002) Development of reference ranges in elite athletes for markers of altered erythropoiesis. Haematologica 87, 1248-1257.
28. Sottas P.E., Robinson N. & Saugy M. (2010) The athlete's biological passport and indirect markers of blood doping. Handbook of Experimental Pharmacology 195, 305-326.
29. Sottas P.E., Robinson N., Giraud S., Taroni F., Kamber M., Mangin P. & Saugy M. (2006) Statistical classification of abnormal blood profiles in athletes. The International Journal of Biostatistics 2, 1-21.
30. Sottas P.E., Robinson N., Niggli O. & Saugy M. (2008a) A forensic approach to the interpretation of blood doping markers. Law Probability & Risk 7, 191-210.
31. Sottas P.E., Saudan C., Schweizer C., Baume N., Mangin P. & Saugy M. (2008b) From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports. Forensic Science International 174, 166-172.
32. Thiers R.E., Wu G.T., Reed A.H. & Oliver L.K. (1976) Sample stability: a suggested definition and method of determination. Clinical Chemistry 22, 176-183.
33. Tsuda I., Hino M., Takubo T., Katagami T., Kubota H., Kawai S. & Tatsumi N. (1999) First basic performance evaluation XE-2100 haematology analyser. Journal of Automated Methods & Management in Chemistry 21, 127-133.
34. Voss S.C., Flenker U., Majer B. & Schänzer W. (2008) Stability tests for hematological parameters in antidoping analyses. Laboratory Hematology 14, 24-29.
35. World Anti-doping Code (2009) International Standard for Laboratories, V5.0, WADA
36. World Anti-doping Code (2010) Athlete Biological Passport Operating Guidelines and Compilation of Required Elements, V2.0, WADA